Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01370954 · ClinicalTrials.gov registry record
NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
A clinical trial of Mild Cognitive Impairment and Alzheimers Disease, sponsored by Pamlab.
- Completed
- Registry status
- 204
- Enrollment target
- 1
- Study location
NCT01370954 is a study of Mild Cognitive Impairment and Alzheimers Disease that has completed, run by Pamlab. The registered enrollment target is 204 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01370954, a study of Mild Cognitive Impairment and Alzheimers Disease, has completed, sponsored by Pamlab.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be an observational study in which patients who have been prescribed CerefolinNAC® are invited to participate in surveys regarding their experiences with CerefolinNAC®. CerefolinNAC® is a medical food indicated for the distinct nutritional requirements of individuals under treatment for early memory loss with particular emphasis for those individuals diagnosed with or at risk for neurovascular oxidative stress and/or hyperhomocysteinemia; mild to moderate cognitive impairment with or without vitamin B12 deficiency, vascular dementia or Alzheimer's disease. The purpose of this study is to increase the understanding of the role of CerefolinNAC® in managing proper neuronal function in the brain, provide patients with personalized education and support, and contribute to the overall understanding of the needs and concerns of patients being treated for early memory loss.
Conditions Studied
Interventions
- OTHER CerefolinNAC®
Study Locations (1)
North Carolina
- Falls Neurology and Memory Center - Hickory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01370954
The ClinicalTrials.gov registry entry for NCT01370954 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower). The listed sponsor is Pamlab, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which CerefolinNAC® is the first listed.
NCT01370954 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01370954 about?
NCT01370954 is a clinical study titled "NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)". This study will be an observational study in which patients who have been prescribed CerefolinNAC® are invited to participate in surveys regarding their experiences with CerefolinNAC®. CerefolinNAC® is a medical food indicated for the distinct nutritional requirements of individuals under treatment ...
What is the current status of trial NCT01370954?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2011-05. Estimated completion is 2012-12.
What conditions does trial NCT01370954 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Alzheimers Disease, Vascular Dementia, Early Memory Loss.
What interventions are being tested in trial NCT01370954?
The interventions under investigation include: CerefolinNAC® (OTHER).
Who is sponsoring clinical trial NCT01370954?
This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01370954 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.